Mankind Pharma taps Barclays and Deutsche Bank for Rs 13,630 cr acquisition of Bharat Serums & Vaccines

Mankind Pharma has appointed Barclays and Deutsche Bank to arrange financing for its Rs 13,630 crore acquisition of Bharat Serums & Vaccines. The deal will be partly funded through Rs 4,000 crore in internal accruals and the rest via debt. Mankind’s board approved raising ₹7,500 crore in equity and increasing the borrowing limit to ₹12,500 crore.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Xr74ZfY
via IFTTT